C
Chris Smith
Guest
- Several coronavirus vaccine candidates have reached advanced testing phases, showing promising results on volunteers who have received immunizations.
- Final research results might be ready at some point this fall for some of the potential COVID-19 prophylactics, and they may be authorized for emergency use before the end of 2020.
- Jefferies analysts believe the Food and Drug Administration could approve some of the vaccines before the November presidential elections.
- The news will be bullish for the economy and the market, and it could improve Trump’s chances of winning reelection.
The novel coronavirus shut down the world for several months, and the reopening process is proving to be a difficult task. That is especially true in countries or states where the curve hasn’t been really flattened. It’s too early to even talk about the second wave of COVID-19 because the first one is hardly done in many communities. After months of lockdown, most people are looking to return to some sense of normalcy, although not all of them are ready to continue respecting the only measures that can keep them safe. Social distancing, face masks, and proper hygiene are all incredibly important. They’re the only weapons we have to reduce the COVID-19 spread and minimize the risk of exposure until medicine that can cure or prevent the illness is widely available.
The first two drugs that work in COVID-19 therapies have already been identified, but remdesivir and dexamethasone work only in some cases, and that’s not enough. Thankfully, we’ve seen very promising developments when it comes to brand new drugs. More than 130 vaccine candidates have been announced so far, of which around 10 have reached advanced human trial stages. Antibody-based pills are also in the works, and these meds could both cure severe COVID-19 cases and offer temporary immunity. Some of the companies involved in these advanced projects said that regulatory approval for emergency use could come as soon as this fall, and analysts familiar with the biopharmaceutical landscape seem to agree. They went even further to suggest that some of the first vaccines could be given the go-ahead before the November presidential election, though it might not be for the right reasons.
Continue reading...
Today's Top Deals
- 10 deals you don’t want to miss on Sunday: Clorox wipes, 50¢ face masks, Purell in stock, Prime-exclusive deals, more
- Amazon’s 5 best-selling electronics devices of the week might surprise you
- 10 deals you don’t want to miss on Saturday: $1 Honeywell face masks, Purell in stock, crazy Instant Pot deal, more
Trending Right Now:
- Netflix, please don’t cancel these 5 excellent shows
- This startup will send you to space in a balloon, for a price
- Marvel’s new Avengers have begun to assemble
The first coronavirus vaccines could be approved before the November election originally appeared on BGR.com on Sun, 21 Jun 2020 at 13:38:06 EDT. Please see our terms for use of feeds.
Via BRG - Boy Genius Report